Summary of "Winner of Three Minute Thesis '16 | University of Southampton"

Summary — main ideas, methods, findings, and implications

Main ideas / context

Dementia (including Alzheimer’s disease) is a major global problem — cited prevalence is ~46 million people, and about one in three people are at risk of a memory‑impairing disease.
A core problem in Alzheimer’s is failure to clear waste/toxic proteins from the brain. The presenter used a motorway metaphor: healthy blood vessels and clearance pathways are “unblocked motorways” that clear waste; with age these roads develop “potholes,” traffic slows, and toxic proteins accumulate, contributing to brain dysfunction.
Delivering drugs to the brain is difficult because the blood–brain barrier (BBB) blocks many systemically administered drugs.
Cerebrospinal fluid (CSF) provides an alternative delivery route because it bathes the brain and spinal cord, but the precise pathways and efficiency of CSF-to-brain drug entry are poorly understood.

“Unblocked motorways” clear waste; age-related “potholes” slow traffic and allow toxic proteins to accumulate.

Project aim

The project maps the exact pathways by which drugs injected into CSF enter different brain regions. The goal is to create a navigable “Google brain map” of CSF-to-brain entry routes to guide efficient CSF-based drug delivery for Alzheimer’s therapies.

Methodology

Obtain normal and disease animal models (mouse models implied).
Inject candidate drugs directly into the CSF.
Track and map drug distribution from CSF into brain tissue.
Compare different drugs to determine which penetrate brain tissue better and how penetration varies with drug properties.
Identify the precise routes (pathways) by which CSF-delivered drugs enter various brain regions.
Compile these routes into a comprehensive, navigable map (“Google brain map”) to plan optimal delivery paths for different therapeutics.
Use the map to inform future drug design/selection and delivery strategies targeting specific brain regions implicated in Alzheimer’s disease.

Key findings and implications

Specific routes by which CSF-delivered drugs enter the brain have been identified.
Different drugs show markedly different efficiencies of penetration into brain tissue — some penetrate much better than others.
The CSF route has substantial capacity for efficient drug delivery to the brain.
It may be possible to target different brain regions selectively by choosing drugs (or formulations) matched to mapped CSF-to-brain pathways.
Long-term goal: complete a detailed “Google brain map” to optimize CSF-based delivery for developing Alzheimer’s therapeutics.